# Radiation-Induced Synthesis of a Minocycline-Derived Polycyclic Scaffold with Anti-Inflammatory and Antibacterial Effects

**Authors:** Gyeong Han Jeong, Hanui Lee, Tae Hoon Kim, Byung Yeoup Chung, Seung Sik Lee, Hyoung-Woo Bai

PMC · DOI: 10.3390/molecules31030435 · Molecules · 2026-01-27

## TL;DR

Gamma radiation transforms minocycline into a new compound with anti-inflammatory and antibacterial properties.

## Contribution

A novel minocycline derivative, minocyclinosin A, was synthesized via gamma irradiation and shown to have enhanced biological activity.

## Key findings

- Minocyclinosin A was formed through gamma irradiation of minocycline at 30 kGy.
- The compound showed improved anti-inflammatory effects in macrophages and retained antibacterial activity.
- Irradiation at 30 kGy achieved a 78.3% conversion efficiency of minocycline to minocyclinosin A.

## Abstract

Radiation is widely used as a powerful tool for inducing molecular transformation and expanding chemical diversity; however, its application in clinically relevant antibiotics remains limited. Minocycline (1), a clinically used tetracycline antibiotic, was subjected to gamma irradiation at doses of up to 30 kGy, resulting in the formation of a previously unreported radiation-induced derivative, minocyclinosin A (2). The structure of the newly generated compound was elucidated by comprehensive spectroscopic analyses, including one- and two-dimensional nuclear magnetic resonance spectroscopy and high-resolution electrospray ionization mass spectrometry, which revealed extensive A-ring cleavage, degradation, and recyclization to form a unique cyclopenta[b]anthracene-type tetracycline scaffold. Biological evaluation revealed that minocyclinosin A exhibited enhanced anti-inflammatory activity by suppressing lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophages, while maintaining antibacterial activity against skin inflammation-associated Staphylococcus species. High-performance liquid chromatography further demonstrated a clear dose-dependent molecular conversion, with irradiation at 30 kGy affording minocyclinosin A as the major product with a conversion efficiency of approximately 78.3%.

## Linked entities

- **Chemicals:** minocycline (PubChem CID 54675783), nitric oxide (PubChem CID 145068)
- **Diseases:** skin inflammation (MONDO:0002406)

## Full-text entities

- **Diseases:** Inflammatory (MESH:D007249)
- **Chemicals:** Minocycline (MESH:D008911), cyclopenta[b]anthracene-type tetracycline (-), nitric oxide (MESH:D009569), tetracycline (MESH:D013752), lipopolysaccharide (MESH:D008070)
- **Species:** Staphylococcus (genus) [taxon 1279]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12899902/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12899902/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12899902/full.md

---
Source: https://tomesphere.com/paper/PMC12899902